Guyana to benefit from COVID-19 support, vaccines from Argentina

September 7, 2020

President Dr. Irfaan Ali, today held discussions with the President of Argentina, His Excellency Alberto Fernández, concerning collaboration and support for Guyana’s response to the Novel Coronavirus Disease 2019 (COVID-19).

The Argentine President committed his country’s support towards bridging the gaps in Guyana’s COVID-19 response. This includes enhancing Polymerase chain reaction (PCR) testing capacity, along with the provision of equipment and vaccines. 

Guyana and Argentina Flag – Photo Source: https://www.crossed-flag-pins.com/shop/Flags-G/Friendship-Pins-Guyana-XXX/Pins-Guyana-Argentina.html

Argentina has assured that all countries except Brazil will have a guaranteed 20 percent of its demands for the COVID-19 vaccines met. These vaccines are manufactured by AstraZeneca/Oxford vaccine and Pfizer. The vaccines are being developed in Argentina and distributed from Mexico.

The Pfizer vaccine will be ready in November in Argentina, while the AstraZeneca vaccine will be ready by March 2021. The Health Ministers of both countries will meet tomorrow to advance discussions in this regard.

Only on Friday last, Minister of Health Dr. Frank Anthony had disclosed that Guyana is currently engaging Russia on COVID-19 Vaccine to learn more and grasp a better understanding of the vaccine and its effectiveness in treating the infectious disease. Upon completion of Phase 3, Guyana can expect to benefit from the Russian-COVID-19 vaccine.

Article Categories:
Health · News

What are your views on this article?

Discover more from Things Guyana

Subscribe now to keep reading and get access to the full archive.

Continue reading